Arno Therapeutics Inc - ESG Rating & Company Profile powered by AI
This page is a zero-cost ESG analysis for Arno Therapeutics Inc. If you work at Arno Therapeutics Inc and you would like to use your ESG rating, please contact us. This page includes a Q&A section on Arno Therapeutics Inc.
Arno Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Arno Therapeutics Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Arno Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Arno Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Arno Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Arno Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Arno Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Arno Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Arno Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Arno Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Arno Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Arno Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Arno Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Arno Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Arno Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Arno Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Arno Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Arno Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Arno Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Arno Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. is based in Flemington, New Jersey.